Results 81 to 90 of about 13,290 (176)

Antibody Responses against Pneumocystis jirovecii in Health Care Workers Over Time

open access: yesEmerging Infectious Diseases, 2013
In a previous cross-sectional study, we showed that clinical staff working in a hospital had significantly higher antibody levels than nonclinical staff to Pneumocystis jirovecii.
Serena Fong   +9 more
doaj   +1 more source

Central Nervous System Infections in Pediatric Solid Organ Transplant Recipients

open access: yesPediatric Transplantation, Volume 30, Issue 8, August 2026.
CNS infections in SOT recipients are rare and presentation can be subtle. Therefore, a low threshold for evaluation is warranted to minimize the associated mortality. ABSTRACT Background Solid organ transplant (SOT) recipients face an increased risk of central nervous system (CNS) infections due to immunosuppression.
Amna AlSaihati   +10 more
wiley   +1 more source

Colonization by Pneumocystis jirovecii in patients with chronic obstructive pulmonary disease: association with exacerbations and lung function status

open access: yesBrazilian Journal of Infectious Diseases, 2019
Exposure to Pneumocystis jirovecii (P. jirovecii) can lead to a wide variety of presenting features ranging from colonization in immunocompetent patients with lung disease, to invasive infections in immunocompromised hosts. Colonization by this fungus in
Alejandra Cañas-Arboleda   +5 more
doaj   +1 more source

Pneumocystis jirovecii Frenkel

open access: yes, 2018
P. jirovecii prevalence and patients ’ characteristics Among all renal transplant recipients tested (n = 72, including 36 males, 36 females), the mean age was 52.5 ± 13.9 years, range 21–76 years. The mean time after kidney transplantation was 78.7 months, ranging from 5 days to 19 years.
Szydłowicz, Magdalena   +10 more
openaire   +2 more sources

Coinfection pulmonaire par pneumocystis jirovecii et pseudomonas aeruginosa au cours du SIDA: à propos de deux cas

open access: yesThe Pan African Medical Journal, 2015
Rapporter deux cas cliniques de coinfections pulmonaires par Pneumocystis jirovecii et par Pseudomonas aeruginosa chez des patients vivant avec le VIH. Les deux patients étaient âgés respectivement de 32 ans et 46 ans. Un patient a été pris en charge à l'
Savadogo Mamoudou   +3 more
doaj   +1 more source

Pneumocystis pneumonia in a treatment-naive rheumatoid arthritis patient

open access: yesIDCases, 2019
A HIV-negative, newly diagnosed patient with rheumatoid arthritis (RA) was found to have pneumocystis jiroveci pneumonia. The infection was treated with three weeks of atovaquone and corticosteroids.
Anuoluwapo Shobayo   +2 more
doaj   +1 more source

Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations

open access: yesClinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 2015
Pneumocystis jirovecii infection causes fulminant interstitial pneumonia ( Pneumocystis pneumonia, PCP) in patients with rheumatoid arthritis (RA) who are receiving biological and/or nonbiological antirheumatic drugs.
Shunsuke Mori, Mineharu Sugimoto
doaj   +1 more source

PNEUMOCYSTIS JIROVECII PNEUMONIA IN A HIV-NEGATIVE ADULT IN COVID-19 PANDEMIC

open access: yesPakistan Armed Forces Medical Journal, 2020
A 67 years old gentleman presented with shortness of breath, fever and cough. Baseline imaging and routine bloods were consistent with respiratory tract infection.
Muhammad Mohsin Sajjad, Sidra Yousaf
doaj  

Cavitary Pneumocystis jirovecii pneumonia [PDF]

open access: yesQJM: An International Journal of Medicine, 2021
R, MacCann   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy